Chemical.AI and Chemaxon announce collaboration in the integration of scientific information software.

Chemical.AI, a global leader in artificial intelligence (AI) for synthetic route design and prediction, and Chemaxon, a leading company in chemical and biological software development, have announced a strategic partnership that will allow access to Chemical.AI's reverse synthesis tool, ChemAIRS, as an option from Chemaxon's drug discovery platform, Design Hub.
This collaboration creates compatibility between Chemical.AI's ChemAIRS and Chemaxon's Design Hub, enabling a seamless user workflow and one-stop service that integrates compound design tracking and prioritization features from Design Hub with ChemAIRS's diverse strategies for innovative synthetic routes completed in minutes.
For more details, please visit our website.

Inquiry about this news
Contact Us OnlineMore Details & Registration
Details & Registration
Related Links
This is our company's homepage regarding this matter.